Abiopharma

🔍 Su Lisa T (Director)

Company: ADVANCED MICRO DEVICES INC (AMD)

Report Date: 2026-08-18

Detailed Transactions and Holdings:

• Sold 700 shares of Common Stock at $475.9 per share (Direct)
  Date: 2026-08-18 | Code: S | equity_swap_involved: 0 | shares_owned_after: 3,116,456.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Sold 1,100 shares of Common Stock at $477.35 per share (Direct)
  Date: 2026-08-18 | Code: S | equity_swap_involved: 0 | shares_owned_after: 3,115,356.00 | transaction_form_type: 4 | Footnotes: F1, F3
• Sold 2,500 shares of Common Stock at $478.41 per share (Direct)
  Date: 2026-08-18 | Code: S | equity_swap_involved: 0 | shares_owned_after: 3,112,856.00 | transaction_form_type: 4 | Footnotes: F1, F4
• Sold 3,201 shares of Common Stock at $479.45 per share (Direct)
  Date: 2026-08-18 | Code: S | equity_swap_involved: 0 | shares_owned_after: 3,109,655.00 | transaction_form_type: 4 | Footnotes: F1, F5
• Sold 1,900 shares of Common Stock at $480.36 per share (Direct)
  Date: 2026-08-18 | Code: S | equity_swap_involved: 0 | shares_owned_after: 3,107,755.00 | transaction_form_type: 4 | Footnotes: F1, F6
• Sold 1,500 shares of Common Stock at $481.42 per share (Direct)
  Date: 2026-08-18 | Code: S | equity_swap_involved: 0 | shares_owned_after: 3,106,255.00 | transaction_form_type: 4 | Footnotes: F1, F7
• Sold 800 shares of Common Stock at $482.31 per share (Direct)
  Date: 2026-08-18 | Code: S | equity_swap_involved: 0 | shares_owned_after: 3,105,455.00 | transaction_form_type: 4 | Footnotes: F1, F8
• Sold 900 shares of Common Stock at $483.6 per share (Direct)
  Date: 2026-08-18 | Code: S | equity_swap_involved: 0 | shares_owned_after: 3,104,555.00 | transaction_form_type: 4 | Footnotes: F1, F9
• Sold 499 shares of Common Stock at $484.71 per share (Direct)
  Date: 2026-08-18 | Code: S | equity_swap_involved: 0 | shares_owned_after: 3,104,056.00 | transaction_form_type: 4 | Footnotes: F1, F10
• Sold 700 shares of Common Stock at $485.94 per share (Direct)
  Date: 2026-08-18 | Code: S | equity_swap_involved: 0 | shares_owned_after: 3,103,356.00 | transaction_form_type: 4 | Footnotes: F1, F11
• Sold 196 shares of Common Stock at $487.38 per share (Direct)
  Date: 2026-08-18 | Code: S | equity_swap_involved: 0 | shares_owned_after: 3,103,160.00 | transaction_form_type: 4 | Footnotes: F1, F12
• Sold 504 shares of Common Stock at $489.03 per share (Direct)
  Date: 2026-08-18 | Code: S | equity_swap_involved: 0 | shares_owned_after: 3,102,656.00 | transaction_form_type: 4 | Footnotes: F1, F13
• Sold 500 shares of Common Stock at $490.36 per share (Direct)
  Date: 2026-08-18 | Code: S | equity_swap_involved: 0 | shares_owned_after: 3,102,156.00 | transaction_form_type: 4 | Footnotes: F1, F14
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-08-18 | Code: H | nature_of_ownership: By Lisa Su and Daniel Lin Family Trust dated 11/3/2021 | shares_owned_after: 99,211.00
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-08-18 | Code: H | nature_of_ownership: Through the shareholdings of a family member | shares_owned_after: 165.00
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-08-18 | Code: H | nature_of_ownership: Through shareholdings of family member | shares_owned_after: 165.00
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-08-18 | Code: H | nature_of_ownership: By Grantor Retained Annuity Trust 2021B | shares_owned_after: 26,034.00
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-08-18 | Code: H | nature_of_ownership: By Grantor Retained Annuity Trust 2021C | shares_owned_after: 147,617.00
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-08-18 | Code: H | nature_of_ownership: By Grantor Retained Annuity Trust LTS 2022 GRAT B | shares_owned_after: 151,776.00
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-08-18 | Code: H | nature_of_ownership: By Grantor Retained Annuity Trust 2025 GRAT A | shares_owned_after: 151,050.00
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-08-18 | Code: H | nature_of_ownership: By Grantor Retained Annuity Trust 2025 GRAT B | shares_owned_after: 169,527.00

Footnotes:

• F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 9, 2025.
• F2: Transaction executed in multiple trades at prices ranging from $475.67 to $476.26 per share, inclusive. The price reported in column 4 above reflects the weighted average sale price per share. The Reporting Person hereby undertakes to provide the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
• F3: Transaction executed in multiple trades at prices ranging from $476.84 to $477.80 per share, inclusive. The price reported in column 4 above reflects the weighted average sale price per share. The Reporting Person hereby undertakes to provide the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
• F4: Transaction executed in multiple trades at prices ranging from $477.86 to $478.82 per share, inclusive. The price reported in column 4 above reflects the weighted average sale price per share. The Reporting Person hereby undertakes to provide the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
• F5: Transaction executed in multiple trades at prices ranging from $478.89 to $479.88 per share, inclusive. The price reported in column 4 above reflects the weighted average sale price per share. The Reporting Person hereby undertakes to provide the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
• F6: Transaction executed in multiple trades at prices ranging from $479.96 to $480.91 per share, inclusive. The price reported in column 4 above reflects the weighted average sale price per share. The Reporting Person hereby undertakes to provide the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
• F7: Transaction executed in multiple trades at prices ranging from $481.01 to $481.92 per share, inclusive. The price reported in column 4 above reflects the weighted average sale price per share. The Reporting Person hereby undertakes to provide the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
• F8: Transaction executed in multiple trades at prices ranging from $482.03 to $482.81 per share, inclusive. The price reported in column 4 above reflects the weighted average sale price per share. The Reporting Person hereby undertakes to provide the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
• F9: Transaction executed in multiple trades at prices ranging from $483.08 to $484.03 per share, inclusive. The price reported in column 4 above reflects the weighted average sale price per share. The Reporting Person hereby undertakes to provide the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
• F10: Transaction executed in multiple trades at prices ranging from $484.48 to $484.96 per share, inclusive. The price reported in column 4 above reflects the weighted average sale price per share. The Reporting Person hereby undertakes to provide the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
• F11: Transaction executed in multiple trades at prices ranging from $485.71 to $486.30 per share, inclusive. The price reported in column 4 above reflects the weighted average sale price per share. The Reporting Person hereby undertakes to provide the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
• F12: Transaction executed in multiple trades at prices ranging from $487.21 to $487.56 per share, inclusive. The price reported in column 4 above reflects the weighted average sale price per share. The Reporting Person hereby undertakes to provide the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
• F13: Transaction executed in multiple trades at prices ranging from $488.66 to $489.27 per share, inclusive. The price reported in column 4 above reflects the weighted average sale price per share. The Reporting Person hereby undertakes to provide the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
• F14: Transaction executed in multiple trades at prices ranging from $489.76 to $490.66 per share, inclusive. The price reported in column 4 above reflects the weighted average sale price per share. The Reporting Person hereby undertakes to provide the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.